{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:24:24Z","timestamp":1790015064658,"version":"4.0.1"},"reference-count":111,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202501ZYTS161"],"award-info":[{"award-number":["YDZJ202501ZYTS161"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the third most common cancer worldwide, widely prevalent across many countries, and poses a serious threat to human health. With changes in its epidemiology, the incidence of HCC is expected to continue rising. As a class of organic molecules widely distributed in nature, quinone compounds possess notable antioxidant, antibacterial, and antitumor properties. This article selects several quinone compounds that have shown notable research progress in recent years and artificially categorizes them into \u201cplant-derived quinone compounds\u201d and \u201cnon-plant-derived quinone compounds.\u201d We then provide a detailed review of the research findings regarding HCC in vitro and in vivo experiments and clinical trials, including their potential toxic side effects. Additionally, based on the varying toxicity reduction of several selected plant-derived quinones when combined with doxorubicin, we further hypothesize that these plant-derived quinone compounds may also exert detoxifying effects on other non-plant-derived quinones discussed in this article. In summary, quinone compounds still hold significant research value and development potential in the fight against HCC. At the same time, we hope our review will provide valuable insights and inspiration for future research in this field.<\/jats:p>","DOI":"10.3390\/biom15101400","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:20:38Z","timestamp":1759332038000},"page":"1400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Research Progress on Quinone Compounds for the Treatment of Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"15","author":[{"given":"Yaowu","family":"Ye","sequence":"first","affiliation":[{"name":"School Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[{"name":"School Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukang","family":"Miao","sequence":"additional","affiliation":[{"name":"Jilin Province Ginseng Science Research Institute, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Pei","sequence":"additional","affiliation":[{"name":"School Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lin","sequence":"additional","affiliation":[{"name":"School Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Changchun Institute of Anticancer Drugs, Changchun 130033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Huang","sequence":"additional","affiliation":[{"name":"School Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[{"name":"School Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfu","family":"Lv","sequence":"additional","affiliation":[{"name":"Jilin Province Ginseng Science Research Institute, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1021\/acs.jafc.1c03279","article-title":"Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis","volume":"69","author":"Qu","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102406","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma. Nature reviews","volume":"7","author":"Llovet","year":"2021","journal-title":"Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1039\/D4FO02600D","article-title":"Recent research on the physicochemical properties and biological activities of quinones and their practical applications: A comprehensive review","volume":"15","author":"Dong","year":"2024","journal-title":"Food Funct."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1021\/acs.jafc.8b05215","article-title":"Reactions of Quinones-Mechanisms, Structures, and Prospects for Food Research","volume":"66","author":"Schieber","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14786410601130604","article-title":"Quinones from plants of northeastern Brazil: Structural diversity, chemical transformations, NMR data and biological activities","volume":"21","author":"Lemos","year":"2007","journal-title":"Nat. Prod. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gomes de Carvalho, N.K., Wellisson da Silva Mendes, J., and Martins da Costa, J.G. (2023). Quinones: Biosynthesis, Characterization of (13) C Spectroscopical Data and Pharmacological Activities. Chem. Biodivers., 20.","DOI":"10.1002\/cbdv.202301365"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22565","DOI":"10.3390\/molecules201219856","article-title":"Seven New Tetrahydroanthraquinones from the Root of Prismatomeris connata and Their Cytotoxicity against Lung Tumor Cell Growth","volume":"20","author":"Wang","year":"2015","journal-title":"Molecules"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4155\/fmc-2019-0322","article-title":"Novel anthraquinone compounds as anticancer agents and their potential mechanism","volume":"12","author":"Tian","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/np800622a","article-title":"Cytotoxic phenanthrenequinones and 9,10-dihydrophenanthrenes from Calanthe arisanensis","volume":"72","author":"Lee","year":"2009","journal-title":"J. Nat. Prod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.phytochem.2016.04.001","article-title":"Naphthohydroquinones, naphthoquinones, anthraquinones, and a naphthohydroquinone dimer isolated from the aerial parts of Morinda parvifolia and their cytotoxic effects through up-regulation of p53","volume":"130","author":"Kang","year":"2016","journal-title":"Phytochemistry"},{"key":"ref_14","first-page":"4832","article-title":"Regulation of apoptosis by ubiquitination in liver cancer","volume":"13","author":"Li","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1568009623666230418121130","article-title":"The Role of Oxidative Stress in the Development and Therapeutic Intervention of Hepatocellular Carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","article-title":"Role of epithelial to mesenchymal transition in hepatocellular carcinoma","volume":"65","author":"Giannelli","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e70312","DOI":"10.1002\/mco2.70312","article-title":"Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)\/microRNA-302a-3p (miR-302a-3p)\/ATPase Copper Transporting Beta (ATP7B) Axis","volume":"6","author":"Wang","year":"2025","journal-title":"MedComm"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Qin, B., Zeng, Z., Xu, J., Shangwen, J., Ye, Z.J., Wang, S., Wu, Y., Peng, G., Wang, Q., and Gu, W. (2022). Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and \u03b2-catenin. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09684-0"},{"key":"ref_19","first-page":"2365590","article-title":"Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC\/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats","volume":"29","author":"Hassan","year":"2024","journal-title":"Redox Rep. Commun. Free Radic. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kim, Y.S., Lee, Y.M., Oh, T.I., Shin, D.H., Kim, G.H., Kan, S.Y., Kang, H., Kim, J.H., Kim, B.M., and Yim, W.J. (2018). Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103127"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molmed.2019.08.002","article-title":"Cisplatin-Induced Ototoxicity: Updates on Molecular Targets","volume":"25","author":"Gentilin","year":"2019","journal-title":"Trends Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Giacomini, I., Ragazzi, E., Pasut, G., and Montopoli, M. (2020). The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030937"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e12609","DOI":"10.1111\/cpr.12609","article-title":"Inhibition of PI3K\/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial-lysosomal crosstalk","volume":"52","author":"Sheng","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_24","first-page":"403","article-title":"Effect of emodin combined with cisplatin on the invasion and migration of HepG2 hepatoma cells","volume":"74","author":"Yang","year":"2023","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.fitote.2019.03.005","article-title":"Synthesis, biological function and evaluation of Shikonin in cancer therapy","volume":"134","author":"Wang","year":"2019","journal-title":"Fitoterapia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1139\/bcb-2018-0310","article-title":"Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1\u03b1 signaling pathway","volume":"97","author":"Liu","year":"2019","journal-title":"Biochem. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"118796","DOI":"10.1016\/j.lfs.2020.118796","article-title":"Shikonin differentially regulates glucose metabolism via PKM2 and HIF1\u03b1 to overcome apoptosis in a refractory HCC cell line","volume":"265","author":"Yang","year":"2021","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liu, H., Zhang, W., Jin, L., Liu, S., Liang, L., and Wei, Y. (2023). Plumbagin Exhibits Genotoxicity and Induces G2\/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076279"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.03.263","article-title":"Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells","volume":"203","author":"Yao","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/JHC.S452924","article-title":"Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro","volume":"11","author":"Du","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"124424","DOI":"10.1016\/j.ijpharm.2024.124424","article-title":"Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma","volume":"661","author":"Cao","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2433710","DOI":"10.1080\/0886022X.2024.2433710","article-title":"Tanshinone I improves renal fibrosis by promoting gluconeogenesis through upregulation of peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1","volume":"46","author":"Bai","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2174\/0929867328666211108110025","article-title":"Tanshinone IIA: Pharmacology, Total Synthesis, and Progress in Structure-modifications","volume":"29","author":"Huang","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/21691401.2019.1709862","article-title":"Tanshinone I induces cell apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing p53\/DRAM-mediated autophagy in human hepatocellular carcinoma","volume":"48","author":"Liu","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Qian, Z., Feng, N., and Geng, A. (2023). Tanshinone I suppresses hepatocellular carcinoma cells growth through targeting DNA double-strand break repair. Cancer Biol. Ther., 24.","DOI":"10.1080\/15384047.2023.2229958"},{"key":"ref_36","first-page":"83","article-title":"Identification of the molecular mechanisms of Salvia miltiorrhiza relevant to the treatment of osteoarthritis based on network pharmacology","volume":"30","author":"Jiang","year":"2020","journal-title":"Discov. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.2147\/DDDT.S360691","article-title":"Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K\/AKT\/HIF-1\u03b1","volume":"16","author":"Zhao","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"103596","DOI":"10.1016\/j.critrevonc.2022.103596","article-title":"The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study","volume":"170","author":"Santoni","year":"2022","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1756-8722-5-69","article-title":"Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization","volume":"5","author":"Wang","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"ref_40","first-page":"155191","article-title":"Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1","volume":"123","author":"Mao","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2147\/OTT.S161534","article-title":"Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells","volume":"11","author":"Chiu","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6273817","DOI":"10.1155\/2016\/6273817","article-title":"The Effects of Different Extraction Methods on Antioxidant Properties, Chemical Composition, and Thermal Behavior of Black Seed (Nigella sativa L.) Oil","volume":"2016","author":"Mohammed","year":"2016","journal-title":"Evid.-Based Complement. Altern. Med. eCAM"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s11033-014-3137-2","article-title":"Anti-inflammatuar and anti-oxidative effects of Nigella sativa L.: 18FDG-PET imaging of inflammation","volume":"41","author":"Entok","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ibrahim, S., Fahim, S.A., Tadros, S.A., and Badary, O.A. (2022). Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats. J. Biochem. Mol. Toxicol., 36.","DOI":"10.1002\/jbt.23078"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tadros, S.A., Attia, Y.M., Maurice, N.W., Fahim, S.A., Abdelwahed, F.M., Ibrahim, S., and Badary, O.A. (2022). Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415904"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/01635581.2021.1879880","article-title":"Thymoquinone Potentiated the Anticancer Effect of Cisplatin on Hepatic Tumorigenesis by Modulating Tissue Oxidative Stress and Endoplasmic GRP78\/CHOP Signaling","volume":"74","author":"Farghaly","year":"2022","journal-title":"Nutr. Cancer"},{"key":"ref_47","first-page":"53","article-title":"Effect of Rhubarb Aphid Fanghe Xiaoyaofang Decoction on Postoperative TACE Syndrome of Primary Hepatocellular Carcinoma","volume":"31","author":"Hou","year":"2018","journal-title":"Med. Inf."},{"key":"ref_48","first-page":"11","article-title":"Effects of Dahuang Zhechong Pill on liver function and immune function after interventional therapy for liver cancer","volume":"16","author":"Tian","year":"2022","journal-title":"Chin. J. Mod. Drug Appl."},{"key":"ref_49","first-page":"1750","article-title":"Clinical Observation of Rheum officinale Soda Tablets for treating advanced primary liver cancer","volume":"11","author":"Deng","year":"2007","journal-title":"J. Pract. Med."},{"key":"ref_50","first-page":"111","article-title":"The effect of \u03b3 knife the combined application of danshen injections on immune function in patients with primary liver cancer","volume":"30","author":"Zhu","year":"2020","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"ref_51","first-page":"184","article-title":"The clinical efficacy of compound Danshen injection in liver cancer patients and its impact on T cell subsets","volume":"3","author":"Zhang","year":"2004","journal-title":"Chin. J. Integr. Tradit. West. Med. Liver Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"112854","DOI":"10.1016\/j.phytochem.2021.112854","article-title":"Emodin\u2014A natural anthraquinone derivative with diverse pharmacological activities","volume":"190","author":"Semwal","year":"2021","journal-title":"Phytochemistry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jat.1637","article-title":"Toxicological effect of emodin in mouse testicular gene expression profile","volume":"31","author":"Oshida","year":"2011","journal-title":"J. Appl. Toxicol. JAT"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/01480545.2011.589447","article-title":"Toxicity induced by emodin on zebrafish embryos","volume":"35","author":"He","year":"2012","journal-title":"Drug Chem. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.3390\/ijms131113911","article-title":"Injurious effects of emodin on maturation of mouse oocytes, fertilization and fetal development via apoptosis","volume":"13","author":"Chang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.toxlet.2019.05.017","article-title":"Evaluation of the inhibition risk of shikonin on human and rat UDP-glucuronosyltransferases (UGT) through the cocktail approach","volume":"312","author":"Cheng","year":"2019","journal-title":"Toxicol. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/01480545.2018.1536710","article-title":"Cytotoxicity and antigenotoxicity evaluation of acetylshikonin and shikonin","volume":"44","author":"Figat","year":"2021","journal-title":"Drug Chem. Toxicol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2017.09.014","article-title":"Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay","volume":"281","author":"Tang","year":"2017","journal-title":"Toxicol. Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2174\/1389201023666211230113146","article-title":"Plumbagin: A Potential Candidate for Future Research and Development","volume":"23","author":"Thakor","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/0974-8520.182750","article-title":"Comparative toxicity profiles of Plumbago zeylanica L. root petroleum ether, acetone and hydroalcoholic extracts in Wistar rats","volume":"36","author":"Kumar","year":"2015","journal-title":"AYU"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"118535","DOI":"10.1016\/j.ecoenv.2025.118535","article-title":"Plumbagin, a natural derivative of 1,4-naphthoquinone, induces cyclopic phenomenon via increased apoptosis and ROS generation in the early stage of zebrafish embryos","volume":"302","author":"Lim","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/01480545.2011.648326","article-title":"Acute effects of thymoquinone on the pregnant rat and embryo-fetal development","volume":"36","author":"AbuKhader","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"ref_63","first-page":"154632","article-title":"Tanshinone I: Pharmacological activities, molecular mechanisms against diseases and future perspectives","volume":"110","author":"Ke","year":"2023","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.7150\/thno.53170","article-title":"Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wang, T., Wang, C., Wu, Q., Zheng, K., Chen, J., Lan, Y., Qin, Y., Mei, W., and Wang, B. (2017). Evaluation of Tanshinone IIA Developmental Toxicity in Zebrafish Embryos. Molecules, 22.","DOI":"10.3390\/molecules22040660"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"101205","DOI":"10.1016\/j.mam.2023.101205","article-title":"Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming","volume":"93","author":"Mattioli","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5599\/admet.1.3.7","article-title":"The Roles of Doxorubicin in Hepatocellular Carcinoma","volume":"1","author":"Tam","year":"2013","journal-title":"ADMET DMPK"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7150\/jca.7093","article-title":"A target-specific oral formulation of Doxorubicin-protein nanoparticles: Efficacy and safety in hepatocellular cancer","volume":"4","author":"Golla","year":"2013","journal-title":"J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Saddik, M.S., Elsayed, M.M.A., Abdel-Rheem, A.A., El-Mokhtar, M.A., Mosa, E.S., Al-Hakkani, M.F., Al-Shelkamy, S.A., Khames, A., Daha, M.A., and Abdel-Aleem, J.A. (2022). A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091845"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1208\/s12249-019-1316-0","article-title":"Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines","volume":"20","author":"Chen","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1039\/C7BM00866J","article-title":"Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy","volume":"5","author":"Sun","year":"2017","journal-title":"Biomater. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2020.06.017","article-title":"Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma","volume":"489","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhao, R., Cheng, S., Bai, X., Zhang, D., Fang, H., Che, W., Zhang, W., Zhou, Y., Duan, W., and Liang, Q. (2024). Development of an efficient liposomal DOX delivery formulation for HCC therapy by targeting CK2\u03b1. Biotechnol. J., 19.","DOI":"10.1002\/biot.202400050"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.63.12_suppl_6.S15","article-title":"Mechanism of action of mitoxantrone","volume":"63","author":"Fox","year":"2004","journal-title":"Neurology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jjco\/hyx038","article-title":"A Phase I\/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma","volume":"47","author":"Ikeda","year":"2017","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbrc.2019.10.114","article-title":"High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement","volume":"521","author":"Xie","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_78","first-page":"829","article-title":"Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers","volume":"60","author":"Arcamone","year":"1976","journal-title":"Cancer Treat. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01737687","article-title":"Oral idarubicin--an anthracycline derivative with unique properties","volume":"66","author":"Goebel","year":"1993","journal-title":"Ann. Hematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.actbio.2022.12.004","article-title":"Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma","volume":"157","author":"Zheng","year":"2023","journal-title":"Acta Biomater."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19880801)62:3<479::AID-CNCR2820620306>3.0.CO;2-L","article-title":"Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial","volume":"62","author":"Lai","year":"1988","journal-title":"Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.bjc.6602394","article-title":"Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): Results of a phase II study","volume":"92","author":"Valle","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1078-0432.CCR-16-2433","article-title":"Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions","volume":"24","author":"Tak","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1987.5.4.635","article-title":"Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma","volume":"5","author":"Shepherd","year":"1987","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s002709900287","article-title":"Percutaneous mitoxantrone injection for primary and secondary liver tumors: Preliminary results","volume":"21","author":"Lagrange","year":"1998","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nano.2009.01.009","article-title":"A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma","volume":"5","author":"Zhou","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_87","unstructured":"Mitomycin (2012). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00254105","article-title":"High-dose mitomycin C: Activity in hepatocellular carcinoma","volume":"24","author":"Cheirsilpa","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CAD.0b013e328346a0c5","article-title":"Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma","volume":"22","author":"Boulin","year":"2011","journal-title":"Anti-Cancer Drugs"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.12746","article-title":"Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: Results of the IDASPHERE phase I trial","volume":"39","author":"Boulin","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3748\/wjg.v26.i3.324","article-title":"Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma","volume":"26","author":"Roth","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: The good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19851215)56:12<2751::AID-CNCR2820561205>3.0.CO;2-O","article-title":"Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients","volume":"56","author":"Sciarrino","year":"1985","journal-title":"Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0676.1985.tb00256.x","article-title":"Hepatocellular carcinoma in Italy: Report of a clinical trial with intravenous doxorubicin","volume":"5","author":"Colombo","year":"1985","journal-title":"Liver"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(85)80777-7","article-title":"Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study","volume":"1","author":"Dunk","year":"1985","journal-title":"J. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00204-016-1759-y","article-title":"Pathways of cardiac toxicity: Comparison between chemotherapeutic drugs doxorubicin and mitoxantrone","volume":"90","author":"Damiani","year":"2016","journal-title":"Arch. Toxicol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001813-199010000-00002","article-title":"Mitomycin C: Mechanism of action, usefulness and limitations","volume":"1","author":"Verweij","year":"1990","journal-title":"Anti-Cancer Drugs"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1148\/radiology.152.1.6203138","article-title":"Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules","volume":"152","author":"Ohnishi","year":"1984","journal-title":"Radiology"},{"key":"ref_99","first-page":"505","article-title":"Idarubicin: A second-generation anthracycline","volume":"25","author":"Fields","year":"1991","journal-title":"DICP Ann. Pharmacother."},{"key":"ref_100","first-page":"155105","article-title":"Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD","volume":"121","author":"Dai","year":"2023","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Tuo, H., Li, W., Zhao, W., Zhao, J., Li, D., and Jin, L. (2024). Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1\/Nrf2 pathway in mice. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-51675-7"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Karabulut, D., Ozturk, E., Kaymak, E., Akin, A.T., and Yakan, B. (2021). Thymoquinone attenuates doxorubicin-cardiotoxicity in rats. J. Biochem. Mol. Toxicol., 35.","DOI":"10.1002\/jbt.22618"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/10520295.2022.2111465","article-title":"Thymoquinone alleviates doxorubicin induced acute kidney injury by decreasing endoplasmic reticulum stress, inflammation and apoptosis","volume":"97","author":"Kaymak","year":"2022","journal-title":"Biotech. Histochem. Off. Publ. Biol. Stain Comm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/0960327120924108","article-title":"Thymoquinone is a protective agent that reduces the negative effects of doxorubicin in rat testis","volume":"39","author":"Kaymak","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_105","first-page":"154439","article-title":"Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway","volume":"106","author":"Jiang","year":"2022","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"ref_106","first-page":"154471","article-title":"Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX\/MEK\/ERK1\/2 pathway","volume":"107","author":"Xu","year":"2022","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cbdd.13141","article-title":"Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents","volume":"91","author":"Qiu","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.drudis.2021.07.013","article-title":"Thymoquinone: A small molecule from nature with high therapeutic potential","volume":"26","author":"Malik","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e242315","DOI":"10.1148\/radiol.242315","article-title":"Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial","volume":"315","author":"Liu","year":"2025","journal-title":"Radiology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10637-023-01377-0","article-title":"Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study","volume":"41","author":"Zhao","year":"2023","journal-title":"Investig. New Drugs"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00270-023-03621-9","article-title":"Transarterial Chemoembolization Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma (IDADOX): Protocol for a Randomized, Non-inferiority, Double-Blind Trial","volume":"47","author":"Choi","year":"2024","journal-title":"Cardiovasc. Interv. Radiol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/10\/1400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:14:33Z","timestamp":1760156073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/10\/1400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":111,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["biom15101400"],"URL":"https:\/\/doi.org\/10.3390\/biom15101400","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}